Abstract
Overactive bladder (OAB) is a clinical symptom complex whose hallmark is the symptom of urinary urgency, usually accompanied by frequency and nocturia, with or without urgency incontinence. Historically, urodynamics (UDS) evaluation has not been recommended in the initial evaluation of OAB, since it is defined primarily by clinical symptoms. As the pathophysiology of the OAB complex has become more clearly elucidated from recent studies, the role of UDS has again become a topic of discussion as a tool that can provide objective data to reflect these new findings. The utility of UDS in the diagnosis and treatment of OAB is still evolving, but in certain clinical scenarios, especially when empiric treatment has failed, it can provide definitive information that can identify associated pathologies and/or alter the treatment course. Herein, we will discuss the current literature regarding use of UDS in OAB patients and offer our own opinions as to its use.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Abrams P, Cardoza LD, Fall M, et al. The standardization of terminology of lower tract function: report from the Standardization Sub-Committee of the International Continence Society. Neurourol Urodyn. 2002;21:167.
Coyne KS, Sexton CC, Irwin DE, et al. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11):1388–95.
Maake C, Landman M, Wang X, et al. Expression of smoothelin in the normal and the overactive human bladder. J Urol. 2006;175:1152.
Digesu GA, Khullar V, Cardozo L, et al. Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn. 2003;22:105–8.
Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006;175:191–4.
Flisser AJ, Walmsley K, Blaivas JG. Urodynamic classification of patients with symptoms of overactive bladder. J Urol. 2003;169:529–33.
Caruso DJ, Kanagarajah P, Cohen BL, et al. What is the predictive value of urodynamics to reproduce clinical findings of urinary frequency, urge urinary incontinence, and/or stress urinary incontinence? Int Urogynecol J. 2010;21(10):1205–9.
Pannek J, Pieper P. Clinical usefulness of ambulatory urodynamics in the diagnosis and treatment of lower urinary tract dysfunction. Scand J Urol Nephrol. 2008;42:428–32.
Radley SC, Rosario DJ, Chapple CR, et al. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity? J Urol. 2001;166:2253–8.
Lowenstein L, Pham T, Abbasy S, et al. Observations related to urinary sensation during detrusor overactivity. Neurourol Urodyn. 2009;28:497–500.
Renganathan A, Cartwright R, Cardozo L, et al. Quality control in urodynamics: analysis of an international multi-center study. Neurourol Urodyn. 2009;28:380–4.
Heslington K, Hilton P. Ambulatory monitoring and conventional cystometry in asymptomatic female volunteers. Br J Obst Gynecol. 1996;103:434–41.
Fan YH, Lin CC, Lin AT, et al. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity? J Chin Med Assoc. 2011;74(10):455–9.
• Guralnick ML, Grimsley G, Liss M, et al. Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity. Int Urogynecol J. 2010;21:325-329. This study presents a review of 146 women with overactive bladder to distinguish patients with and without urodynamic detrusor overactivity. On urodynamics, patients with detrusor overactivity were found to have abnormal sensation with strong desire and urgency at much lower bladder volumes, suggesting that there are objective differences between the two groups.
Boy S, Schurch B, Mehnert U, et al. The effects of tolterodine on bladder filling sensations and perception thresholds to intravesical electoral stimulation: method and initial results. BJU Int. 2007;100:574–8.
Finney SM, Andersson KE, Gillespie JI, et al. Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions? BJU Int. 2006;98:503–7.
Rapp DE, Neil NJ, Govier FE, et al. Bladder sensation measures and overactive bladder. J Urol. 2009;182(3):1050–4.
McNeill SA, Hargreave TB, Geffriaud-Ricouard C, et al. Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a pooled analysis of eleven controlled studies with alfuzosin. Urology. 2001;57:459–65.
Kolman C, Girman CJ, Jacobsen SJ, et al. Distribution of post-void residual urine volume in randomly selected men. J Urol. 1999;161:122–7.
Van Vernrooij GE, Van Melick HH, Eckhardt MD, et al. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol. 2002;168:605–9.
Ronchi P, Gravina GL, Galatioto GP, et al. Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity. Neurourol Urodyn. 2009;28(1):52–7.
Te A, Ghafar MA, OStad E, et al. Nomogram and urodynamic predictors of urinary retention in men with BPH and bladder outlet obstruction [Abstract]. Presented at the American Urological Association Annual Meeting. Anaheim, CA: June 2-7, 2001;1996.
• Blaivas JG, Marks BK, Weiss JP, et al. Differential diagnosis of overactive bladder in men. J Urol 2009;182:2814-2817. This is a descriptive study that highlights the coexisting pathological conditions in men with overactive bladder. Many underlying urologic pathologies contribute to overactive bladder symptoms, and the authors stressed that a more complete knowledge of differential diagnosis in this patient population should improve treatment success. Overactive bladder should be considered to be a symptom complex, not a syndrome.
Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn. 2000;19(5):553–64.
Kershen RT, Appell RA. De novo urge syndrome and detrusor instability after anti-incontinence surgery: current concepts, evaluation, and treatment. Curr Urol Rep. 2002;3:345–53.
Nitti VW, Rovner ES, Bavendam T. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent to the urodynamic finding of detrusor overactivity. BJU Int. 2010;105:126–1275.
Cohen BL, Barboglio P, Rodriguez D, et al. Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units. Neurourol Urodyn. 2009;28:205–8.
Chou EC, Flisser AJ, Panagopoulos G, et al. Effective treatment for mixed urinary incontinence with a pubovaginal sling. J. Urol. 2003;170: 494–497, 2003
Serels SR, Rackley RR, Appell RA. Surgical treatment for stress urinary incontinence associated with valsalva induced detrusor instability. J Urol. 2000;163:884–7.
•• Winters CJ, Dmochowski RR, Goldman HB, et al.: American Urological Association Guideline on Adult Urodynamics, Linthicum, MD. American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU); 2012. This latest guideline represents a systematic review of literature in the appropriate selection of urodynamics in characterization of complex lower urinary tract symptoms and voiding dysfunction. Peer reviewed publications relevant to the use of urodynamics in diagnosis, management, and prognosis were analyzed, yielding 393 studies after pre-determined inclusion/exclusion criteria.
Disclosure
M.P. Rutman, D.Y. Cha and J.G. Blaivas have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rutman, M.P., Cha, D.Y. & Blaivas, J.G. How Do Urodynamics Findings Influence the Treatment of the Typical Patient With Overactive Bladder?. Curr Urol Rep 13, 370–378 (2012). https://doi.org/10.1007/s11934-012-0265-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11934-012-0265-x